Arrowhead Research Corporation to Form New Nanotech Subsidiary - News Item

Arrowhead Research Corporation announced today that it has entered into an agreement to form a new majority-owned subsidiary to commercialise an ultrathin crystal film (nanofilm) technology that has been developed by Dr. Harry A. Atwater and his research group at the California Institute of Technology. The agreement between Arrowhead Research Corporation, Dr. Atwater, and Caltech provides for the grant of a fully-paid exclusive license to the new company to utilize the technology for commercial application.

The technology is expected to provide advancements in semiconductor technology, in which device active region optical and electrical properties can be optimally engineered independently of the underlying substrate's thermal, dielectric and mechanical properties. The technology enables fabrication of high-quality single crystal semiconductor (e.g., InP, Ge, GaAs) and oxide (e.g., BaTiO3, LiNbO3, PMNPT) nanometer thickness films as surface layers transferred onto low-cost substrates (Si, Sapphire, glass) and would enable superior device/system performance at lower cost in applications such as photonics/ULSI electronics integration, light-emitting diode and laser arrays, HBTs for wireless communications and high efficiency solar cells.

Arrowhead has also agreed to sponsor research at Caltech under the direction of Dr. Atwater to exploit a new ferroelectric film synthesis technique recently developed by the Atwater group to make nanoscale piezoelectric devices suitable for integration into microelectromechanical systems (MEMS) on silicon substrates.

Posted 9th March 2004

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Arrowhead Pharmaceutical. (2016, August 02). Arrowhead Research Corporation to Form New Nanotech Subsidiary - News Item. AZoNano. Retrieved on December 03, 2024 from https://www.azonano.com/article.aspx?ArticleID=620.

  • MLA

    Arrowhead Pharmaceutical. "Arrowhead Research Corporation to Form New Nanotech Subsidiary - News Item". AZoNano. 03 December 2024. <https://www.azonano.com/article.aspx?ArticleID=620>.

  • Chicago

    Arrowhead Pharmaceutical. "Arrowhead Research Corporation to Form New Nanotech Subsidiary - News Item". AZoNano. https://www.azonano.com/article.aspx?ArticleID=620. (accessed December 03, 2024).

  • Harvard

    Arrowhead Pharmaceutical. 2016. Arrowhead Research Corporation to Form New Nanotech Subsidiary - News Item. AZoNano, viewed 03 December 2024, https://www.azonano.com/article.aspx?ArticleID=620.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this article?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.